Mitchell, Judy A, Cardwell, Jacqueline M, Leach, Heather, Walker, Caray A, Le Poder, Sophie, Decaro, Nicola, Rusvai, Miklos, Egberink, Herman, Rottier, Peter, Fernandez, Mireia, Fragkiadaki, Eirini, Shields, Shelly, Brownlie, Joe, dI&I I&I-1, LS Klinisch Onderzoek Wagenaar, LS Virologie, dI&I I&I-4, Royal Veterinary College - University of London, Virologie UMR1161 (VIRO), École nationale vétérinaire d'Alfort (ENVA)-Institut National de la Recherche Agronomique (INRA)-Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Department of Veterinary Medicine, University of Cambridge [UK] (CAM), Department of Pathology, University of Veterinary Medicine, Department of Infectious Diseases and Immunology, Utrecht University [Utrecht], Universitat Autònoma de Barcelona (UAB), Faculty of Animal Science and Aquaculture, Agricultural University of Athens, Zoetis, Zoetis Animal Health, Petplan Charitable Trust, dI&I I&I-1, LS Klinisch Onderzoek Wagenaar, LS Virologie, and dI&I I&I-4
Highlights • The largest study of its kind in the field to date, including high-risk kennelled dogs, and for the first time, pet dogs and dogs from other cohorts. • A clearly identifiable link between disease and the emerging pathogens: canine respiratory coronavirus and canine pneumovirus. • Provides, substantial evidence of CIRD and the circulation of the novel pathogens studied in pet dogs, and dogs from other cohorts. • Demonstrates the role and limitations of current vaccine strategies in managing CIRD outbreaks, and the need for including emerging pathogens., Canine infectious respiratory disease (CIRD) is a major cause of morbidity in dogs worldwide, and is associated with a number of new and emerging pathogens. In a large multi-centre European study the prevalences of four key emerging CIRD pathogens; canine respiratory coronavirus (CRCoV), canine pneumovirus (CnPnV), influenza A, and Mycoplasma cynos (M. cynos); were estimated, and risk factors for exposure, infection and clinical disease were investigated. CIRD affected 66% (381/572) of the dogs studied, including both pet and kennelled dogs. Disease occurrence and severity were significantly reduced in dogs vaccinated against classic CIRD agents, canine distemper virus (CDV), canine adenovirus 2 (CAV-2) and canine parainfluenza virus (CPIV), but substantial proportions (65.7%; 201/306) of vaccinated dogs remained affected. CRCoV and CnPnV were highly prevalent across the different dog populations, with overall seropositivity and detection rates of 47% and 7.7% for CRCoV, and 41.7% and 23.4% for CnPnV, respectively, and their presence was associated with increased occurrence and severity of clinical disease. Antibodies to CRCoV had a protective effect against CRCoV infection and more severe clinical signs of CIRD but antibodies to CnPnV did not. Involvement of M. cynos and influenza A in CIRD was less apparent. Despite 45% of dogs being seropositive for M. cynos, only 0.9% were PCR positive for M. cynos. Only 2.7% of dogs were seropositive for Influenza A, and none were positive by PCR.